Mumbai, July 6 -- In an exchange filing, the company said Sreekant Sreedharan, General Manager - Sales & Marketing, has been placed under judicial custody until 17 July 2026 following an investigation initiated on 3 July 2026.

According to the disclosure, the proceedings have been initiated under the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985, over an alleged procedural lapse related to a single export transaction involving an identified product.

Supriya Lifescience said the matter pertains to the concerned employee and, based on the information currently available, is not expected to have any material impact on the company's operations, financial position or corporate governance.

The company said it is evaluating the ...